Genetic testing offered directly after the diagnosis of colorectal cancer: A pilot study on the reactions of patients

Genetic Counseling

Volumn 20, Issue 4, 2009, Pages 317-325

  Landsbergen, K M ^a   Prins, J B ^a   Brunner, H G ^a   Hoogerbrugge, N ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Lynch syndrome; MSI test; Patient reactions; Treatment face

Indexed keywords

ADULT; ANXIETY; ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; COLORECTAL CANCER; COPING BEHAVIOR; FAMILIAL CANCER; FAMILY COUNSELING; FOLLOW UP; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; MICROSATELLITE INSTABILITY; PATIENT ATTITUDE; PHYSICAL CAPACITY; PSYCHOLOGICAL ASPECT; SEMI STRUCTURED INTERVIEW; TUMOR LOCALIZATION;

ADAPTATION, PSYCHOLOGICAL; ADULT; ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIAGNOSIS, DIFFERENTIAL; GENETIC TESTING; HUMANS; MICROSATELLITE INSTABILITY; MIDDLE AGED; NETHERLANDS; PILOT PROJECTS; REFERRAL AND CONSULTATION;

EID: 76049120565     PISSN: 10158146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. AARNIO M., MECKLIN J.P., AALTONEN L.A., NYSTROM-LAHTI M., JARVINEN H.J.: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int. J Cancer, 1995, 64, 430-433.
2. AKTAN-COLLAN K., HAUKKALA A., PYLVANAINEN K., JARVINEN H.J., AALTONEN L.A., PELTOMAKI P., RANTANEN E., KAARIAINEN H., MECKLIN J.P.: Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J. Med. Genet., 2007,44, 732-738.
3. ALLAL A.S., GERVAZ P., GERTSCH P., BERNIER J., ROTH A.D., MOREL P., BIERI S.: Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int. J. Radiat. Oncol. Biol. Phys., 2005, 61, 1129-1135.
4. ARNDT V., MERX H., STEGMAIER C., ZIEGLER H., BRENNER H.: Quality of life in patients with colorectal cancer 1 year after diagnosis compared to the general population: a population-based study. J Clin. Oncol., 2004, 22, 4829-4836.
5. BLEIKER E.M., GROSFELD F.J., HAHN D.E., HONING C.: Psychosocial care in family cancer clinics in The Netherlands: a brief report. Patient. Educ.Couns., 2001, 43, 205-209.
6. BRAUN V., CLARKE V.: Using thematic analysis in psychology. Qualitative Research in Psychology, 2006, 3, 77-101.
7. DE BRUIN J.H., KIEVIT W., LIGTENBERG M.J., NAGENGAST F.M., ADANG E.M., RUERS T.J., KLEIBEUKER J.H., SIJMONS R.H., VAN KRIEKEN J.H., HOOGERBRUGGE N.: [Hereditary intestinal cancer will be detected more frequently if the pathologist select patients with colorectal cancer for microsatellite instability testing]. Ned. Vjdschr. Geneeskd., 2005, 149, 1792-1798.
8. DORVAL M., PATENAUDE A.F., SCHNEIDER K.A., KIEFFER S.A., DIGIANNI L., KALKBRENNER K.J., BROMBERG J.I., BASILI L.A., CALZONE K., STOPFER J., WEBER B.L., GARBER J.E.: Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J. Clin. Oncol., 2000, 18, 2135-2142.
9. ENGEL J., KERR J., SCHLESINGER-RAAB A., ECKEL R., SAUER H., HOLZEL D.: Quality of life in rectal cancer patients: a four-year prospective study. Ann. Surg., 2003, 238, 203-213.
10. JARVINEN H.J., AARNIO M., MUSTONEN H., AKTAN-COLLAN K., AALTONEN L.A., PELTOMAKI P., DE LA CHAPELLE A., MECKLIN J.P.: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 2000, 118, 829-834.
11. KlEVIT W., DE BRUIN J.H., ADANG E.M., SEVERENS J.L., KLEIBEUKER J.H., SIJMONS R.H., RUERS T.J., NAGENGAST F.M., VASEN H.F., VAN KRIEKEN J.H., LIGTENBERG M.J., HOOGERBRUGGE N.: Cost effectiveness of a new strategy to identify HNPCC patients. Gut, 2005, 54, 97-102.
12. KOPP I., BAUHOFER A., KOLLER M.: Understanding quality of life in patients with colorectal cancer: comparison of data from a randomised controlled trial, a population based cohort study and the norm reference population. Inflamm. Res., 2004, 53 Suppl 2, S130-S135.
13. UNDSBERGEN K., VERHAAK C., KRAAIMAAT F., HOOGERBRUGGE N.: Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Earn. Cancer, 2005, 4, 115-119.
14. LYNCH H.T., DE LA CHAPELLE A.: Hereditary colorectal cancer. N. Engl. J Med., 2003, 348, 919-932.
15. PENTZ R.D., PETERSON S.K., WATTS B., VERNON S.W., LYNCH P.M., KOEHLY L.M., GRITZ E.R.: Hereditary nonpolyposis colorectal cancer family members' perceptions about the duty to inform and health professionals' role in disseminating genetic information. Genet. Test., 2005, 9, 261-268.
16. PORTEOUS M., DUNCKLEY M., APPLETON S., CATT S., DUNLOP M., CAMPBELL H., CULL A.: Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study. Br. J Cancer, 2003, 89, 1400-1402.
17. ROSS L., BILD-NIELSEN A.G., THOMSEN B.L., KARLSEN R.V., BOESEN E.H., JOHANSEN C.: Quality of life of Danish colorectal cancer patients with and without a stoma. Support. Care Cancer, 2006, 15, 505-513.
18. SCHMIDT C.E., BESTMANN B., KUCHLER T., LONGO W.E., ROHDE V., KREMER B.: Gender differences in quality of life of patients with rectal cancer. A five-year prospective study. World J. Surg., 2005, 29, 1630-1641.
19. SERMIJN E., GOELEN G., TEUGELS E., KAUFMAN L., BONDUELLE M., NEYNS B., POPPE B., DE PAEPE A., DE GRÈVE J.: The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. J. Med. Genet., 2004, 41, e23.
20. SNELLEN A.: A multicausal model for problem analysis (translated from Dutch "Een multicausaal model van probleemanalyse"). Basic model for methodological psychosocial help by social workers (translated from Dutch "Basismodel voor methodisch hulpverlenen in het maatschappelijk werk"). Coutinho, 2000, 232-245.
21. SUTHERS G., ARMSTRONG J., MCCORMACK J., TROTT D.: Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J. Med. Genet., 2005, 43, 665-670.
22. VASEN H.F., MECKLlN J.P., KHAN P.M., LYNCH H.T.: The International Collaborative Group on HNPCC. Anticancer Res., 1994, 14, 1661-1664.
23. VASEN H.F., WATSON P., MECKLlN J.P., LYNCH H.T.: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 1999, 116, 1453-1456.
24. Vereniging Integrale Kancercentra (VIKC). Landelijke Richtlijn Erfelijke Darmkanker. www.oncoline.nl. 9-1-2008.
25. Vereniging Klinische Genetica Nederland (VKGN). www.vkgn.org. 2008.